Mary Theresa Coelho is Director of First Wave BioPharma, Inc.. Currently has a direct ownership of 20,237 shares of FWBI, which is worth approximately $20,034. The most recent transaction as insider was on Jan 02, 2024, when has been sold 19,633 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.2K
0% 3M change
76.12% 12M change
Total Value Held $20,034

Mary Theresa Coelho Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2024
BUY
Grant, award, or other acquisition
-
19,633 Added 49.24%
20,237 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
84,745 Added 50.0%
84,745 Common Stock

Also insider at

BDSI
BIODELIVERY SCIENCES INTERNATIONAL INC Healthcare
CINC
CinCor Pharma, Inc. Healthcare
HOOK
HOOKIPA Pharma Inc. Healthcare
NOTV
Inotiv, Inc. Healthcare
GMDA
Gamida Cell Ltd. Healthcare
MTC

Mary Theresa Coelho

Director
Raleigh, NC

Track Institutional and Insider Activities on FWBI

Follow First Wave BioPharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FWBI shares.

Notify only if

Insider Trading

Get notified when an First Wave Bio Pharma, Inc. insider buys or sells FWBI shares.

Notify only if

News

Receive news related to First Wave BioPharma, Inc.

Track Activities on FWBI